LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 93.96 | 27.76 | 2616 | 6849 | 0.3820 | 0.7719 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 93.96 | 27.76 | 8590 | 6849 | 1.2542 | 1.0578 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 95.66 | 27.76 | 322 | 6712 | 0.0480 | 0.3628 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 95.66 | 27.76 | 9232 | 6712 | 1.3753 | 1.0821 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 95.66 | 27.76 | 2495 | 6712 | 0.3717 | 0.7650 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 95.66 | 27.76 | 8838 | 6712 | 1.3166 | 1.0707 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 1.95 | 27.76 | 454 | 225 | 2.0165 | 1.5229 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 1.95 | 27.76 | 461 | 225 | 2.0476 | 1.5357 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 1.95 | 27.76 | 669 | 225 | 2.9714 | 1.8685 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 3.66 | 27.76 | 565 | 283 | 1.9899 | 1.4554 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 3.66 | 27.76 | 526 | 283 | 1.8526 | 1.4036 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 3.66 | 27.76 | 762 | 283 | 2.6838 | 1.6844 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 5.36 | 27.76 | 639 | 320 | 1.9946 | 1.4323 | MN20160318_Q01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 5.36 | 27.76 | 627 | 320 | 1.9572 | 1.4192 | MN20160318_Q01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 5.36 | 27.76 | 806 | 320 | 2.5159 | 1.5977 | MN20160318_Q01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | D18 |